Dapoxetine: LY 210448

Drugs in R and D

Volumn 6, Issue 5, 2005, Pages 307-311

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; DAPOXETINE; PLACEBO; SILDENAFIL; TADALAFIL; BENZYLAMINE DERIVATIVE; NAPHTHALENE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR;

ABSENCE OF SIDE EFFECTS; AREA UNDER THE CURVE; CLINICAL TRIAL; DRUG ACTIVITY; DRUG APPROVAL; DRUG BINDING; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG SYNTHESIS; DRUG TOLERABILITY; HEADACHE; HUMAN; NAUSEA; NONHUMAN; PATENT; PREMATURE EJACULATION; PRIORITY JOURNAL; REVIEW; TACHYCARDIA; UROGENITAL TRACT DISEASE; ANIMAL; DEPRESSION; TREATMENT OUTCOME;

ANIMALS; BENZYLAMINES; CLINICAL TRIALS; DEPRESSION; HUMANS; NAPHTHALENES; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 33644816995     PISSN: 11745886     EISSN: 11745886     Source Type: Journal    
DOI: 10.2165/00126839-200506050-00007     Document Type: Review

References (12)

1. Reid LR, Robertson DW, Thompson DC. Effects of stereochemistry on inhibition of the serotonin (5HT) uptake carrier by LY243917. FASEB Journal 4: A988, 28 Feb 1990
2. PPD Inc. PPD Acquires Lilly's Patents for Dapoxetine; Adjusts Earnings Guidance for 2003. Media Release: 18 Dec 2003. Available from URL: http://www.ppdi.com
3. PPD Inc. PPD Amends Dapoxetine License Agreement with ALZA; Adjusts Financial Guidance for 2004. Media Release: 5 Jan 2004. Available from URL: http://www.ppdi.com
4. ALZA Corporation. New Drug Application Submitted for Dapoxetine for Premature Ejaculation. Media Release: 28 Dec 2004. Available from URL: http://www.alza.com
5. Ortho Urology. First Medication Developed To Treat Premature Ejaculation Demonstrates Improvement In Control, Satisfaction tion And Time. Media Release: 23 May 2005. Available from URL: http://www.ortho-mcneil.com
6. Franklin RB, Manzione BM. Metabolism and disposition of the serotonin reuptake inhibitor, LY210448 hydrochloride in mice, rats, and dogs. Pharmacologist 32: 174, No. 3, 1990
7. Franklin RB, Manzione BM, Wrighton SA. Metabolism of the serotonin-reuptake inhibitor, LY210448 in several animal species. Pharmacologist 33: 208, No. 3, 1991
8. Dresser M, Gidwani S, Gupta SK, et al. Pharmacokinetics of single and multiple escalating doses of dapoxetine in healthy volunteers. Clinical Pharmacology and Therapeutics 75: 32, No. 2, Feb 2004
9. Desai D, Dresser M, Jazrawi RP, et al. Dapoxetine for the treatment of premature ejaculation: lack of interaction with ethanol. Journal of Urology 173 (Suppl.): 239, No. 4, Apr 2005
10. Desai D, Dresser M, Jazrawi RP, et al. Dapoxetine for the treatment of premature ejaculation: lack of interaction with PDE5 inhibitors. Journal of Urology 173 (Suppl.): 201, No. 4, Apr 2005
11. Althof SE, Kell S, Miloslavsky M, et al. Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation. Journal of Urology 173 (Suppl.): 201-2, No. 4, Apr 2005
12. Chester A, Gengo PJ, Giuliano F, et al. Monoaminergic transporter binding and inhibition profile of dapoxetine, a medication for the treatment of premature ejaculation. Journal of Urology 173 (Suppl.): 239, No. 4, Apr 2005